Immunomedics (IMMU) - moderated | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Immunomedics (IMMU) - moderated

An SI Board Since September 2006

Posts	SubjectMarks	Bans	Symbol
63363	356	15	IMMU

Emcee: idahoranch1	Type: Moderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
63149	I see this as a contrary indicator. I think the fear/panic trade is mostly done	stockdoc77	-	6/26/2025
63148	$10 hahaha. Bring it on. Reminds me of BoA dumping on TGTX the past two years, a	ghettogoulash	-	6/26/2025
63147	HC Wainwright & Co. analyst Mitchell Kapoor downgrades Sarepta Therapeutics(	luckydog88	1	6/25/2025
63146	I'm in the same boat and averaged down earlier this year just to get whacked	stockdoc77	3	6/23/2025
63145	Well dammit, a week ago I was so secure that a SP of upper/mid 30’s was a solid	Olecranon	3	6/18/2025
63144	From the WSJ today: New FDA Chief Wants to Fast-Track Some Drugs, Use More AI C	luckydog88	-	6/17/2025
63143	It’s a relatively small position so mostly averaging down here…	erippetoe	-	6/16/2025
63142	as tempted as I am to buy more, I think I already own a lot ............ might	luckydog88	1	6/16/2025
63141	I also doubled my position today in taxable account…	erippetoe	-	6/16/2025
63140	Was only holding 125 shares of SRPT at $100+. Added 400 today, now at 975. These	ghettogoulash	1	6/16/2025
63139	downgrades this morning: HC Wainwright Downgrades Sarepta Therapeutics to Sell	luckydog88	1	6/16/2025
63138	SRPT is 23 pre market: finance.yahoo.com	luckydog88	-	6/16/2025
63137	themedicinemaker.com some quotes from RFK in the article: Speaking in a podca	luckydog88	1	6/14/2025
63136	Thanks for the corrections, GG. I also fully agree with your characterization o	Olecranon	-	6/13/2025
63135	So the common denominator here is not Elevidys, but the vector itself, which mak	ghettogoulash	1	6/12/2025
63134	SRPT: A couple of corrections. Elevidys already has Full Approval in ambulatory	ghettogoulash	1	6/12/2025
63133	Perhaps I was a little too glib in my first statement regarding SRPT risks. Jus	Olecranon	1	6/11/2025
63132	I’m going push back on that a little; the worst is just beginning.	dorightbythem	1	6/11/2025
63131	That is certainly the hope. I have been increasing holdings in this range for a	luckydog88	-	6/10/2025
63130	IMHO RFKJr’s worst is already priced in.	Olecranon	1	6/10/2025
63129	well i guess the risk is RFK and the uncertainty he brings. this is what happen	luckydog88	1	6/9/2025
63128	IMHO, it’s rare to see a stock a stock like Sarepta with so much near/medium ter	Olecranon	-	6/9/2025
63127	came across this today: 03:01 PM EDT, 06/09/2025 (MT Newswires) -- Sarepta Ther	luckydog88	2	6/9/2025
63126	Scotiabank Upgrades Sarepta Therapeutics to Sector Outperform From Sector Perfor	luckydog88	2	6/6/2025
63125	re: SRPT undervalued Right, but every damn time there's a buying opportunit	erickerickson	1	6/5/2025

Go to reply# or date (mm/dd/yy):